Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulmatrix Inc PULM

Healthcare Biotechnology
Pulmatrix, Inc. is a biopharmaceutical company. The Company is focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with unmet medical needs using its patented iSPERSE technology. The Company’s proprietary product pipeline includes treatments for central nervous system (CNS) disorders such as acute migraine and serious... see more

Recent & Breaking News (NDAQ:PULM)

15 Biggest Mid-Day Losers For Monday

Benzinga.com  March 20, 2017

A Peek Into The Markets: U.S. Stock Futures Edge Lower; Crude Oil Drops

Benzinga.com  March 20, 2017

15 Biggest Mid-Day Gainers For Friday

Benzinga.com  March 17, 2017

22 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  March 16, 2017

Pulmatrix Reports 2016 Financial Results; Provides 2017 Outlook on Pulmonary Disease Pipeline

PR Newswire March 10, 2017

Technical Reports on Biotech Stocks -- Bioverativ, Pulmatrix, PharmAthene, and Zosano Pharma

PR Newswire March 10, 2017

Trump's Intentions to Streamline Drug-Approval Process Fueling Biotech Optimism

PR Newswire Europe Non Regulatory February 7, 2017

20 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  February 7, 2017

15 Biggest Mid-Day Gainers For Monday

Benzinga.com  February 6, 2017

The Biotech Market Grows as Demand for New Therapeutics Increases

PR Newswire February 6, 2017

Pulmatrix Announces Over $3.0 Million Registered Direct Offering

PR Newswire February 3, 2017

22 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  February 2, 2017

Pulmatrix Announces $5 Million Registered Direct Offering

PR Newswire January 30, 2017

25 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  January 27, 2017

Mid-Afternoon Market Update: Crude Oil Up 1.2%; Progress Software Shares Plunge

Benzinga.com  January 17, 2017

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  January 17, 2017

Pulmatrix Drug Candidate Receives "Qualified Infectious Disease Product" (QIDP) Designation from the FDA

PR Newswire January 17, 2017

Improving the Lives of Patients with Respiratory Diseases

Marketwired December 20, 2016

Pulmatrix Receives Patents Important to its Inhaled Drug Delivery Technology

PR Newswire December 19, 2016

Pulmatrix Chief Scientific Officer David Hava Featured on Health Media Now

PR Newswire November 29, 2016